These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20664013)

  • 41. Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies.
    Fang YT; Lin CF; Liao PC; Kuo YM; Wang S; Yeh TM; Shieh CC; Su IJ; Lei HY; Lin YS
    Mol Immunol; 2010 Feb; 47(5):1000-9. PubMed ID: 20015551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.
    Iwata-Yoshikawa N; Uda A; Suzuki T; Tsunetsugu-Yokota Y; Sato Y; Morikawa S; Tashiro M; Sata T; Hasegawa H; Nagata N
    J Virol; 2014 Aug; 88(15):8597-614. PubMed ID: 24850731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human immunopathogenesis of severe acute respiratory syndrome (SARS).
    Cameron MJ; Bermejo-Martin JF; Danesh A; Muller MP; Kelvin DJ
    Virus Res; 2008 Apr; 133(1):13-9. PubMed ID: 17374415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
    Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
    Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular Basis of Coronavirus Virulence and Vaccine Development.
    Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I
    Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
    Quan C; Li C; Ma H; Li Y; Zhang H
    Clin Microbiol Rev; 2020 Oct; 34(1):. PubMed ID: 33055229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates.
    Wu D; Tu C; Xin C; Xuan H; Meng Q; Liu Y; Yu Y; Guan Y; Jiang Y; Yin X; Crameri G; Wang M; Li C; Liu S; Liao M; Feng L; Xiang H; Sun J; Chen J; Sun Y; Gu S; Liu N; Fu D; Eaton BT; Wang LF; Kong X
    J Virol; 2005 Feb; 79(4):2620-5. PubMed ID: 15681462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential characteristics of the early stage of lung inflammation induced by SARS-CoV Nucleocapsid protein related to age in the mouse.
    Zhu YG; Qu JM
    Inflamm Res; 2009 Jun; 58(6):312-20. PubMed ID: 19234811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathological changes in masked palm civets experimentally infected by severe acute respiratory syndrome (SARS) coronavirus.
    Xiao Y; Meng Q; Yin X; Guan Y; Liu Y; Li C; Wang M; Liu G; Tong T; Wang LF; Kong X; Wu D
    J Comp Pathol; 2008 May; 138(4):171-9. PubMed ID: 18343398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2.
    Yoshikawa N; Yoshikawa T; Hill T; Huang C; Watts DM; Makino S; Milligan G; Chan T; Peters CJ; Tseng CT
    J Virol; 2009 Jun; 83(11):5451-65. PubMed ID: 19297479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell-mediated immune response to respiratory coronaviruses.
    Channappanavar R; Zhao J; Perlman S
    Immunol Res; 2014 Aug; 59(1-3):118-28. PubMed ID: 24845462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor.
    Tseng CT; Huang C; Newman P; Wang N; Narayanan K; Watts DM; Makino S; Packard MM; Zaki SR; Chan TS; Peters CJ
    J Virol; 2007 Feb; 81(3):1162-73. PubMed ID: 17108019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel coronavirus associated with severe acute respiratory syndrome.
    Ksiazek TG; Erdman D; Goldsmith CS; Zaki SR; Peret T; Emery S; Tong S; Urbani C; Comer JA; Lim W; Rollin PE; Dowell SF; Ling AE; Humphrey CD; Shieh WJ; Guarner J; Paddock CD; Rota P; Fields B; DeRisi J; Yang JY; Cox N; Hughes JM; LeDuc JW; Bellini WJ; Anderson LJ;
    N Engl J Med; 2003 May; 348(20):1953-66. PubMed ID: 12690092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques.
    Kobinger GP; Figueredo JM; Rowe T; Zhi Y; Gao G; Sanmiguel JC; Bell P; Wivel NA; Zitzow LA; Flieder DB; Hogan RJ; Wilson JM
    Vaccine; 2007 Jul; 25(28):5220-31. PubMed ID: 17559989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1.
    Hogan RJ; Gao G; Rowe T; Bell P; Flieder D; Paragas J; Kobinger GP; Wivel NA; Crystal RG; Boyer J; Feldmann H; Voss TG; Wilson JM
    J Virol; 2004 Oct; 78(20):11416-21. PubMed ID: 15452265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model.
    Cameron MJ; Kelvin AA; Leon AJ; Cameron CM; Ran L; Xu L; Chu YK; Danesh A; Fang Y; Li Q; Anderson A; Couch RC; Paquette SG; Fomukong NG; Kistner O; Lauchart M; Rowe T; Harrod KS; Jonsson CB; Kelvin DJ
    PLoS One; 2012; 7(9):e45842. PubMed ID: 23029269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunopathogenesis of coronavirus infections: implications for SARS.
    Perlman S; Dandekar AA
    Nat Rev Immunol; 2005 Dec; 5(12):917-27. PubMed ID: 16322745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
    Zhang YY; Li BR; Ning BT
    Front Immunol; 2020; 11():2033. PubMed ID: 32922406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Symptoms of infection caused by SARS coronavirus in laboratory mice and guinea pigs.
    Chepurnov AA; Dadaeva AA; Malkova EM; Kolesnikov SI; Sandakhchiev LS
    Dokl Biol Sci; 2004; 397(1):310-3. PubMed ID: 15508583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.